Member Info for MasterRSI

re- Some buying while is cheap, let's see next "AT" shouldn't be far away

YES eventually the "AT" was activated and no more cheap shares

Some buying while is cheap, let's see next "AT" shouldn't be far away

and better yet, someone is willing to buy at 11.10p naturally from the order book

strong support at bid 11p at the moment

Is at the moment at support on the chart @ 11p

chart ... https://tinyurl.com/y6fjulsh

The chart shows clearly an Inverse Head & Shoulders is developing, now at the last stage and looking for 0.20p with time being the target

https://uk.advfn.com/p.php?pid=chartscreenshot&u=sGAo4YTAPzhQmCcGY4mceWFbDTi%2FJbDeSKqtobQBAuI%3D

Bleach ... lace with Bourbon

FrankFeedback
it may bee that.....

a twitter rumour that the french regulators will be granting an authorisation (known as an ATU or Authorisation Temporaire d'Utilisation) for its therapeutic use in specific circumstances.

Source a French doctor: https://twitter.com/MARYau_MCU_PH/status/1311409036311621632

Naturally at this rate, the volume is going to be higher than yesterday, that already was higher than usual.
Volume and rising = Bullish
chart with volume ... http://uk.advfn.com/p.php?pid=staticchart&s=L%5EKOD&width=600&height=200&p=1&t=1&dm=2&vol=1&cb=

Some larger trades are paying a premium just now

is now surging ahead as shorters must be closing positions and others getting into the UP movement at the chart.

Slowly rising from the lows, showing a good look at the monthly Candlestick chart.

chart ... http://uk.advfn.com/p.php?pid=staticchart&s=L%5EHUR&width=700&height=350&p=1&t=1&dm=2&vol=0&cb=

The company say "strong cash position £8,8m, they have used £7,7m during the last year or £3,5m on the last 6 month on loses of (1,168,529) on the last 6 month,

LOSS FOR THE PERIOD (1,168,529)
Period end -------------- 30/06/20 30/06/19 31/12/19
---------------------- ------ GBP GBP GBP
Cash and cash equivalents 8,881,309 15,527,814 12,318,536

"AT" with 22p and 22.20p not seen for some time

the share price has managed a movement up
but so far there is not much buying yet

by Andrew Hore from interactive investor | 25th September 2020

This year’s AIM awards will be announced on 15 October and the shortlists for the individual awards have been revealed. They include many of the old favourites and a few new names – so who is likely to win the 2020 trophies? .........

Best technology
Last year’s winner, medical device developer Creo Medical (LSE:CREO), is back on the shortlist, while cell engineering services provider MaxCyte (LSE:MXCT) won the award in 2016. Both companies have made further progress but the award is likely to be between Renalytix AI (LSE:RENX)and Synairgen (LSE:SNG).

RenalytixAI has developed the KidneyIntelX test that can be used for the early diagnosis and improved management of chronic kidney disease patients. The company has agreed pricing with the US authorities and gained a Nasdaq listing. There is potential for the technology to be used as a companion diagnostic to other treatments.

Respiratory treatments developer Synairgen (LSE:SNG) is one of those AIM drug developers that has been around for years and has made slow, and not always smooth, progress. Inhaled interferon beta treatment SNG001 has been the main focus of the company and it has proved to be a safe and effective treatment for Covid-19 in hospitalised patients. There could be revenues generated from this treatment by the end of this year.

Best guess: Synairgen .......
Https://www.ii.co.uk/analysis-commentary/who-will-win-big-years-aim-awards-ii513583

on the way up alright 78 v 80p

from a double bottom

Link to chart https://uk.advfn.com/p.php?pid=chartscreenshot&u=%2BEHxmW9%2B1xehFNKsXX0imGkl4PsuXUdNKZM9igot6hM%3D

finally on the way UP

Someone is buying a few 5K and has pushed the bid to 76p now
Wonder if there is a large buyer and MMs are buying the 5K from each other to push the price up

yes they are going places Builders by now and CRST the best in % terms

CRST 187.10 +13.40 +7.71%
BDEV 455.50 +17.00 +3.88%
TW. 103.25 +2.50 +2.33%